| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/03/2006 | CA2213842C Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| 10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/28/2006 | WO2006100922A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | WO2006045319A3 Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure |
| 09/28/2006 | US20060217421 Fortifier |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705176A1 Carboxamide derivative and use thereof |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1704140A1 Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 09/27/2006 | EP1703903A1 Pharmaceutical composition for treating stress incontinence and/or mixed incontinence |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | EP0951286B1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 09/27/2006 | CN1837226A Separation of medical derivatives from phoenix-tail fern and use thereof |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1836714A Soft capsule for treating prostate disease and its preparation method and quality control method |
| 09/27/2006 | CN1836703A Medicine for treating acute urinary tract infection and its preparing method |
| 09/27/2006 | CN1836535A Tea |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 09/26/2006 | US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | CA2254953C Therapies for chronic renal failure |
| 09/21/2006 | WO2006099459A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
| 09/21/2006 | WO2006099457A1 (s)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof |
| 09/21/2006 | WO2006099433A1 Pure duloxetine hydrochloride |
| 09/21/2006 | WO2006096931A1 Renal repair and regeneration |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211025 Molecular signatures of commonly fatal carcinomas |
| 09/21/2006 | US20060210657 Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
| 09/21/2006 | US20060210635 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 09/21/2006 | US20060210606 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 09/21/2006 | CA2599478A1 Process for the purification of duloxetine hydrochloride |
| 09/21/2006 | CA2599475A1 Pure duloxetine hydrochloride |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702919A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701717A1 Method of treating elevated plasma homocysteine levels in esrd patients |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835924A Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor |
| 09/20/2006 | CN1835921A N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 09/20/2006 | CN1275936C Crystals of hydroxynorephedrine derivative |
| 09/20/2006 | CN1275633C Chinese traditional preparation for treating prostatitis |
| 09/20/2006 | CN1275630C Medicine for treating chronic kidney failure and its preparing process |
| 09/20/2006 | CN1275628C Immediat effect medicinal paste for treating prostatitis |
| 09/20/2006 | CN1275627C Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method |
| 09/20/2006 | CN1275615C Levulose absorption retardant, compound, food and levulose absorption repressor |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006094900A1 Carnitine-containing peritoneal dialysis solution having improved biocompatibility |
| 09/14/2006 | WO2006061336A3 Oral compositions for absorption of phosphorus compounds |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205770 Acid addition salts such as (-)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (-)-(2S,3S)-tartrate; for treatment of various M3 receptor-mediated diseases such as urinary incontinence, respiratory diseases such as chronic obstructive pulmonary disease |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |